We have all seen the positive surveys identifying pharmacists among the most trusted professionals, and as the most accessible healthcare provider. For most people, the community pharmacy is their most frequently visited healthcare location, and to reinforce these high standards, pharmacists seek to advance the pharmacy profession, increase our visibility, and expand the breadth of service offerings we provide.
Flibanserin (Addyi; Valeant Pharmaceuticals, North America) is the first medication approved by the US Food and Drug Administration (FDA) for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
The National Council for Prescription Drug Programs (NCPDP), a standards development organization (SDO), has served the pharmacy services industry for approximately 40 years. The organization—which has ushered in a real-time environment for this segment of the healthcare industry—has made a practice of putting its vision into action to transform a paper-based environment into an automated one, laying a foundation for the continued expansion of pharmacist-administered clinical services.
Responsible for the deaths of approximately 130,000 Americans each year, stroke is a leading cause of serious, long-term disability. It is the fifth leading cause of death for Americans, and costs the United States an estimated $34 billion annually in healthcare services, medications, and missed days of work. Because chances of survival are increased when emergency treatment begins faster, it is important to know the warning signs and symptoms of stroke.
Yellow fever is a viral disease produced by mosquitoes, and is widespread in sub-Saharan Africa and tropical South America. Responsible for approximately 200,000 cases of clinical disease globally, the yellow fever virus also causes 30,000 deaths annually. Clinical disease ranges from mild febrile illness to severe disease with jaundice and hemorrhage.
Results 1 - 6 of 6